跳轉至內容
Merck
全部照片(1)

重要文件

46916

Sigma-Aldrich

芴甲氧羰酰胺

≥99.0% (HPLC)

同義詞:

Fmoc-酰胺

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C15H13NO2
CAS號碼:
分子量::
239.27
Beilstein:
4188192
MDL號碼:
分類程式碼代碼:
12352005
PubChem物質ID:
NACRES:
NA.22
暫時無法取得訂價和供貨情況

化驗

≥99.0% (HPLC)

形狀

solid

mp

201-204 °C

溶解度

dioxane: 15 mg/mL, clear, colorless

應用

peptide synthesis

SMILES 字串

NC(=O)OCC1c2ccccc2-c3ccccc13

InChI

1S/C15H13NO2/c16-15(17)18-9-14-12-7-3-1-5-10(12)11-6-2-4-8-13(11)14/h1-8,14H,9H2,(H2,16,17)

InChI 密鑰

ZZOKVYOCRSMTSS-UHFFFAOYSA-N

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Choi Yi Li et al.
Chembiochem : a European journal of chemical biology, 20(1), 46-50 (2018-09-19)
Urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are two serine proteases that contribute to initiating fibrinolysis by activating plasminogen. uPA is also an important tumour-associated protease due to its role in extracellular matrix remodelling. Overexpression of uPA has
Simon J de Veer et al.
The Biochemical journal, 469(2), 243-253 (2015-05-20)
Laskowski inhibitors regulate serine proteases by an intriguing mode of action that involves deceiving the protease into synthesizing a peptide bond. Studies exploring naturally occurring Laskowski inhibitors have uncovered several structural features that convey the inhibitor's resistance to hydrolysis and

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務